Skip to main content
Envío gratis en todos los pedidos
888-559-3802
VitabaseIngredientes

andrographolide

Condiciones de Salud24
Tabla de contenidos

Otros Nombres

PasionariaRaíz de PerejilPerejil de JardínPasto del Congreso(5β,9R,10α,14S)-3α,14,15,18-Tetrahydroxylabdane-8(20),12-diene-16-oic acid gamma-lactoneSanta Maria Fiebre ReducidaAmbrosía Falsa3-(2-(Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthyl)ethylidene)dihydro-4-hydroxyfuran-2(3H)-onePapaya VerdeHoja de PapayaAceite Esencial de Menta PiperitaFruta de PapayaPectina de ManzanaPectina de CítricosPeonía ChinaConcentrado de Proteína de ArrozMezcla de Proteína VegetalVid de PasiónChuanxinlianAislado de Proteína de GuisanteÉchinacée d'IndeSemilla de PapayaBrotes de GuisanteZarcillos de GuisanteAislado de Proteína de GuisanteProteína de Guisante DivididoPeptidasa DPPIVPepsina GástricaEnzima DPP4Pawpaw AmericanaKalmeghKalmeghaKariyatÁrbol de PawpawFruta de PawpawManzana de CremaJugo de PeraEnzimas PectolíticasMahatitaFruta de PeraPera AsiáticaPectina de FrutaBrotes de Guisante VerdeAceite de Hoja de Menta PiperitaPepsina PorcinaRaíz de Peonía BlancaBai ShaoProteína de Guisante AmarilloPera EuropeaPectina de Cítricos Modificada穿心莲

Sinopsis

La maltasa ácida, también conocida como alfa-glucosidasa ácida (GAA), es una enzima lisosomal responsable de descomponer el glucógeno—una forma almacenada de glucosa—en glucosa libre dentro de las células. Esta enzima funciona en el ambiente ácido del lisosoma y desempeña un papel fundamental en el mantenimiento del equilibrio energético celular, particularmente en el tejido muscular y hepático. Hidroliza tanto los enlaces glucosídicos alfa-1,4 como alfa-1,6 en el glucógeno, permitiendo la liberación de glucosa para uso metabólico.

La deficiencia o mal funcionamiento de la maltasa ácida conduce a una condición conocida como enfermedad de Pompe (enfermedad de almacenamiento de glucógeno tipo II), un trastorno genético raro caracterizado por la acumulación de glucógeno en el músculo y otros tejidos. Esta acumulación resulta en debilidad muscular progresiva, dificultades respiratorias y posible compromiso cardíaco, dependiendo de la edad de inicio y la gravedad de la deficiencia enzimática. La enfermedad de Pompe se clasifica en formas de inicio infantil, juvenil y adulto, con una gravedad que corresponde al grado de actividad enzimática residual.

En la medicina clínica, la maltasa ácida ha adquirido especial importancia debido al desarrollo de la terapia de reemplazo enzimático (ERT) mediante alfa-glucosidasa ácida recombinante. Esta terapia ha mejorado significativamente los resultados para los pacientes con enfermedad de Pompe, particularmente aquellos diagnosticados tempranamente. Si bien la maltasa ácida en sí no se utiliza en suplementos ni en productos herbales, su papel en el metabolismo del glucógeno y la función lisosomal la convierte en un foco clave en la medicina metabólica y neuromuscular.

Uso Histórico:
La maltasa ácida no tiene un uso medicinal histórico o tradicional, ya que su existencia y función fueron descubiertas a través de la investigación biomédica del siglo XX. La enzima fue identificada en relación con la enfermedad de Pompe, descrita por primera vez por el patólogo neerlandés Johannes C. Pompe en 1932, aunque la comprensión molecular de la deficiencia de maltasa ácida llegó más tarde. El uso terapéutico de la maltasa ácida recombinante se desarrolló solo en las últimas décadas, marcando un avance significativo en la terapia genética y metabólica.

Sin embargo, el objetivo más amplio de apoyar la fuerza muscular, la resistencia y la salud metabólica ha sido durante mucho tiempo central en los sistemas de curación tradicionales. Si bien la maltasa ácida en sí era desconocida, los síntomas asociados con su deficiencia—como debilidad muscular, fatiga y dificultad para respirar—eran tratados tradicionalmente con tónicos restauradores y hierbas que apoyan la energía. En la Medicina Tradicional China (TCM), hierbas como el astrágalo y el cordyceps se usaban para potenciar el "Qi" (energía vital), mientras que en el Ayurveda, el ashwagandha y el shilajit se usaban para restaurar el vigor y la resistencia.

De esta manera, el enfoque antiguo en el tratamiento de los trastornos musculares y relacionados con la energía mediante remedios botánicos es paralelo a las estrategias modernas orientadas a apoyar el metabolismo del glucógeno y la función energética celular, aunque los tratamientos modernos ahora operan con precisión molecular. La maltasa ácida es un ejemplo de cómo la ciencia contemporánea ha profundizado la comprensión de las condiciones metabólicas, permitiendo el desarrollo de terapias que salvan vidas mientras refleja los principios perdurables del equilibrio energético y la integridad muscular que se encuentran en las filosofías de curación tradicionales.

Condiciones de Salud

Condiciones de salud que andrographolide puede ayudar a apoyar.

  • EccemaCientífico

    Andrographolide is the primary bioactive diterpenoid from Andrographis paniculata that covalently inhibits NF-κB, suppressing pro-inflammatory mediators. A 2009 double-blind RCT (Clinical Rheumatology, n=60 RA patients) found andrographolide-standardized extract significantly reduced joint tenderness, swelling, and pain vs. placebo.

  • EdemaCientífico

    Andrographolide is the principal diterpene lactone of Andrographis paniculata that inhibits NF-κB signaling, reduces Th2 cytokines (IL-4, IL-5, IL-13), and decreases eosinophilic airway inflammation in preclinical asthma models. It is among the most studied phytochemicals for NF-κB-mediated anti-inflammatory activity relevant to asthma.

  • Andrographolide, the active diterpenoid lactone from Andrographis paniculata, has demonstrated ability to block T-cell activation and significantly reduce experimental autoimmune encephalomyelitis (EAE) symptoms in mice by inhibiting T-cell and antibody responses to myelin antigens. It has established immunomodulatory and anti-inflammatory properties.

  • EndometriosisCientífico

    Andrographolide is the principal active diterpene lactone of Andrographis paniculata and the mechanistic basis for the herb's clinical efficacy in acute respiratory infections including bronchitis. It exerts immunomodulatory and antiviral effects confirmed by a 2023 systematic review. NF-κB inhibition is the key anti-inflammatory pathway.

  • ApendicitisCientífico

    Andrographolide, the primary bioactive diterpenoid from Andrographis paniculata, has well-documented anti-inflammatory activity supported by both mechanistic laboratory research and human clinical trials. It suppresses key pro-inflammatory pathways—most notably NF-κB—reducing cytokines such as TNF-α, IL-1β, IL-6, and COX-2. Clinical evidence is strongest for chronic inflammatory conditions including ulcerative colitis and, to a lesser extent, rheumatoid arthritis and osteoarthritis, though overall human trial data remain limited in scale.

  • ArritmiaCientífico

    Andrographolide is the principal bioactive diterpenoid of Andrographis paniculata responsible for its anti-cold and antiviral effects. It inhibits NF-κB via covalent binding to the p50 subunit. Clinical evidence from multiple RCTs using standardized Andrographis extracts (SHA-10) documents significant reductions in cold symptom severity and duration. It also shows direct in vitro antiviral activity against influenza A.

  • Andrographolide, the primary active compound of Andrographis paniculata, has been evaluated in clinical trials for mild-to-moderate active ulcerative colitis. A randomized trial in 120 UC patients found it produced clinical remission and response rates comparable to mesalazine. It inhibits NF-κB and reduces pro-inflammatory cytokines.

  • Andrographolide, the principal diterpene lactone from Andrographis paniculata, demonstrates antipyretic effects comparable to paracetamol in animal studies. It reduces fever by inhibiting COX-2 expression and suppressing pyrogenic cytokines such as IL-1β and TNF-α. It has a long history of use in TCM for febrile illness.

  • FlotadoresCientífico

    Andrographolide, the primary active diterpene of Andrographis paniculata, has been tested in placebo-controlled RCTs in ulcerative colitis. The proprietary extract HMPL-004 (containing andrographolide) was superior to placebo in inducing remission and clinical response in UC in two RCTs. It suppresses multiple pro-inflammatory pathways including NF-κB and Th1/Th17 responses.

  • Olor de piesCientífico

    Andrographolide is the primary bioactive diterpene from Andrographis paniculata with demonstrated insulin-sensitizing properties in cell and animal models. It activates PPAR-γ and AMPK, enhances GLUT4 translocation, and reduces hepatic gluconeogenesis. Traditional Ayurvedic use of the parent plant for diabetes is well-documented.

  • Andrographolide is the primary active diterpenoid from Andrographis paniculata demonstrating documented hepatoprotective effects via NF-κB inhibition, Nrf2 activation, glutathione restoration, and antioxidant enzyme upregulation. Preclinical studies confirm it prevents hepatotoxin-induced liver injury. Its hepatoprotective activity is specifically cited in peer-reviewed research and is the basis for Andrographis paniculata's liver-support classification.

  • Andrographolide is the principal bioactive diterpenoid lactone from Andrographis paniculata, with clinical and preclinical evidence for reducing airway inflammation, suppressing NF-κB-mediated cytokine production, and supporting recovery from respiratory infections. Animal and in vitro studies demonstrate protection against lung injury.

  • Andrographolide, the primary bioactive diterpene lactone of Andrographis paniculata, drives the herb's potent NF-κB inhibition and anti-inflammatory effects relevant to chronic Lyme disease. It is central to Lyme integrative protocols for immune modulation and cytokine reduction. Research has shown it can modulate host immune responses potentially impacting B. burgdorferi clearance. Evidence is primarily mechanistic and in vitro.

  • CongestiónCientífico

    Andrographolide demonstrates in vitro activity against Plasmodium falciparum (low micromolar IC50), Leishmania donovani, and Trypanosoma brucei, with confirmed anti-malarial efficacy in animal models. It is the primary diterpene lactone antiparasitic compound from Andrographis paniculata.

  • ResacaCientífico

    Andrographolide is the principal bioactive diterpenoid from Andrographis paniculata with direct evidence in pneumonia-relevant animal models. It significantly attenuates lung injury in both S. aureus and Klebsiella pneumoniae pneumonia. Oral andrographolide tablets are clinically used in China for respiratory tract infections. It modulates NF-κB and cytokine production central to pneumonia pathophysiology.

  • ConjuntivitisCientífico

    The principal bioactive diterpene lactone of Andrographis paniculata, andrographolide exerts direct anti-inflammatory and immunomodulatory effects relevant to post-illness recovery. It inhibits NF-κB and JAK-STAT signaling, reduces cytokine storm mediators, and has been shown in preclinical models to reduce influenza A virus-induced inflammation.

  • Andrographolide, the principal bioactive diterpene of Andrographis paniculata, demonstrates antiviral activity against multiple respiratory viruses and reduces inflammatory cytokines relevant to post-viral recovery. Clinical and preclinical data show NF-κB inhibition, IL-1β suppression, and antiviral interference with viral RNA synthesis. It underpins the evidence for the parent herb in COVID-19 and viral respiratory illness recovery.

  • Andrographolide, the principal bioactive of Andrographis paniculata, potently inhibits NF-κB and reduces TNF-α, IL-1β, and IL-6 production. Multiple preclinical studies in collagen-induced arthritis models and clinical evidence with the standardized ParActin extract support its use as an adjunct in RA for reducing joint pain and stiffness.

  • Andrographolide, the principal diterpene of Andrographis paniculata, inhibits NF-κB and reduces pro-inflammatory cytokine production in nasal epithelial cells, exhibiting antiviral and immunomodulatory activity against URTI pathogens. A 2023 PMC systematic review confirmed its mechanistic role in URTI treatment including nasal symptom relief. It is the pharmacological basis for Andrographis's clinical efficacy.

  • HemocromatosisCientífico

    Andrographolide is the principal bioactive diterpene in Andrographis paniculata and the compound responsible for its anti-inflammatory and immune-modulatory effects studied in URTIs including sinusitis. Clinical trials of Kan Jang (standardized andrographolide preparation) showed reduced sinusitis symptoms in double-blind trials.

  • Andrographolide is the primary active diterpene of Andrographis with documented anti-inflammatory (NF-κB, COX-2 inhibition), immunostimulatory, and antiviral effects. Clinical trials using andrographolide-standardized Andrographis extracts show significant reduction of sore throat and pharyngitis symptom scores versus placebo. It is the mechanism underlying Andrographis's recognized efficacy for upper respiratory infections.

  • HerpesCientífico

    Andrographolide is the principal bioactive diterpene lactone from Andrographis paniculata with documented anti-inflammatory and antimicrobial properties relevant to tonsillitis. A multicenter Phase 4 RCT evaluated andrographolide sulfonate specifically in acute tonsillitis patients. It inhibits NF-κB, suppressing pro-inflammatory cytokines involved in tonsillar inflammation.

  • DefensividadCientífico

    Andrographolide is the principal diterpene lactone from Andrographis paniculata responsible for anti-URTI activity. It inhibits NF-κB-mediated inflammation, modulates immune responses, and has demonstrated antiviral activity against influenza and RSV. Clinical RCTs using andrographolide-standardized extracts show significant URTI symptom improvement.

  • Andrographolide, the primary diterpenoid from Andrographis paniculata, inhibits replication of multiple viruses including influenza, coronavirus, HSV, dengue, and HIV. It acts both directly on viral targets and via immune cell modulation. Phase I clinical data in HIV patients showed increased CD4+ lymphocyte counts.

Sistemas Corporales

Sistemas corporales que andrographolide puede ayudar a apoyar.

  • No hay sistemas corporales disponibles.
Únete a nuestro boletín

Mantente informado. Mantente saludable.

Recibe consejos de suplementos de expertos, descuentos exclusivos y recomendaciones de productos en tu bandeja de entrada